Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Nucleus Hybrid L24 Extended Duration Post Approval Study

NCT: NCT02379273 · COMPLETED

NCT IDNCT02379273
StatusCOMPLETED
Start Date2015-01-14
Completion2019-03-18
SponsorCochlear (INDUSTRY)
First posted
Last updated

Brief Summary

This post approval study evaluates the long term safety and efficacy of the Nucleus Hybrid L24 Implant System in a group of already implanted recipients.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑